Furthermore, we detected a similar upregulation of the IL-36 signaling pathway in psoriasis-like skin lesions of mice that either develop psoriasis upon IMQ treatment (Figure 1C), or in psoriatic mice that overexpress IL-17A in the epidermis (Figure 1D). The gene discussed is IL17A; the disease is psoriasis.